Clinical Management Resources for ADHD
Mark L. Wolraich, MD
 Professor of Pediatrics
Vanderbilt Child Development Center
Nashville, Tennessee
There is no charge for participating in this educational activity.

Term of Offering:  CME credit for this archived Internet webcast program will be available through September 1, 2002. The original release of this material was June 22nd, 2001. CME credit is offered upon successful completion of the post-test.

 
 
 

Faculty Biography

Mark L. Wolraich, MD
 Dr. Mark L. Wolraich is professor of pediatrics and director of the Division of Child Development at Vanderbilt University. Dr. Wolraich has been involved in multiple editorial projects for prestigious medical journals. He is currently a principal investigator for both state and private bodies in the field of pediatric neurology. Dr. Wolraich has been active nationally in the American Academy of Pediatrics where he chaired the Task Force on Coding Mental Health in Children, a group that developed the DSM-PC Child and Adolescent Version.

Back to Top

Learning Objectives

After completion of this program, participants should be able to:

  • Use effective clinical tools for the diagnosis of ADHD
  • Formulate empirical and psychopharmacological treatment plans for patients with ADHD
  • Describe emerging therapeutic options for patients with ADHD
  • Identify practical management issues in the care of patients with ADHD

Back to Top

Faculty Disclosure

Mark Wolraich, MD 
Formal advisor: Alza Pharmaceuticals; Shire Richwood Inc.; Noven Pharmaceuticals, Inc.; Eli Lilly and Company; East3, Ltd.; Help4life, Inc. Researcher: Alza Pharmaceuticals; Shire Richwood Inc.; Eli Lilly and Company. Educational consultant: Medical Education Systems, Inc. Speakers’ bureau: Medical Education Systems, Inc. 

Back to Top